181 related articles for article (PubMed ID: 19483071)
1. Combinations of cocaine with other dopamine uptake inhibitors: assessment of additivity.
Tanda G; Newman AH; Ebbs AL; Tronci V; Green JL; Tallarida RJ; Katz JL
J Pharmacol Exp Ther; 2009 Sep; 330(3):802-9. PubMed ID: 19483071
[TBL] [Abstract][Full Text] [Related]
2. Dopamine transporter-dependent and -independent striatal binding of the benztropine analog JHW 007, a cocaine antagonist with low abuse liability.
Kopajtic TA; Liu Y; Surratt CK; Donovan DM; Newman AH; Katz JL
J Pharmacol Exp Ther; 2010 Dec; 335(3):703-14. PubMed ID: 20855444
[TBL] [Abstract][Full Text] [Related]
3. The high affinity dopamine uptake inhibitor, JHW 007, blocks cocaine-induced reward, locomotor stimulation and sensitization.
Velázquez-Sánchez C; Ferragud A; Murga J; Cardá M; Canales JJ
Eur Neuropsychopharmacol; 2010 Jul; 20(7):501-8. PubMed ID: 20413276
[TBL] [Abstract][Full Text] [Related]
4. Behavioral and neurochemical effects of the dopamine transporter ligand 4-chlorobenztropine alone and in combination with cocaine in vivo.
Tolliver BK; Newman AH; Katz JL; Ho LB; Fox LM; Hsu K; Berger SP
J Pharmacol Exp Ther; 1999 Apr; 289(1):110-22. PubMed ID: 10086994
[TBL] [Abstract][Full Text] [Related]
5. Relations between stimulation of mesolimbic dopamine and place conditioning in rats produced by cocaine or drugs that are tolerant to dopamine transporter conformational change.
Tanda G; Li SM; Mereu M; Thomas AM; Ebbs AL; Chun LE; Tronci V; Green JL; Zou MF; Kopajtic TA; Newman AH; Katz JL
Psychopharmacology (Berl); 2013 Sep; 229(2):307-21. PubMed ID: 23612854
[TBL] [Abstract][Full Text] [Related]
6. Applicability of the dopamine and rate hypotheses in explaining the differences in behavioral pharmacology of the chloro-benztropine analogs: studies conducted using intracerebral microdialysis and population pharmacodynamic modeling.
Othman AA; Newman AH; Eddington ND
J Pharmacol Exp Ther; 2007 Aug; 322(2):760-9. PubMed ID: 17519385
[TBL] [Abstract][Full Text] [Related]
7. Relationship between in vivo occupancy at the dopamine transporter and behavioral effects of cocaine, GBR 12909 [1-{2-[bis-(4-fluorophenyl)methoxy]ethyl}-4-(3-phenylpropyl)piperazine], and benztropine analogs.
Desai RI; Kopajtic TA; French D; Newman AH; Katz JL
J Pharmacol Exp Ther; 2005 Oct; 315(1):397-404. PubMed ID: 16014753
[TBL] [Abstract][Full Text] [Related]
8. Assessment of reinforcing effects of benztropine analogs and their effects on cocaine self-administration in rats: comparisons with monoamine uptake inhibitors.
Hiranita T; Soto PL; Newman AH; Katz JL
J Pharmacol Exp Ther; 2009 May; 329(2):677-86. PubMed ID: 19228996
[TBL] [Abstract][Full Text] [Related]
9. Preference for distinct functional conformations of the dopamine transporter alters the relationship between subjective effects of cocaine and stimulation of mesolimbic dopamine.
Kohut SJ; Hiranita T; Hong SK; Ebbs AL; Tronci V; Green J; Garcés-Ramírez L; Chun LE; Mereu M; Newman AH; Katz JL; Tanda G
Biol Psychiatry; 2014 Nov; 76(10):802-9. PubMed ID: 24853388
[TBL] [Abstract][Full Text] [Related]
10. Effects of N-substituted analogs of benztropine: diminished cocaine-like effects in dopamine transporter ligands.
Katz JL; Kopajtic TA; Agoston GE; Newman AH
J Pharmacol Exp Ther; 2004 May; 309(2):650-60. PubMed ID: 14755006
[TBL] [Abstract][Full Text] [Related]
11. Atypical dopamine transporter inhibitors R-modafinil and JHW 007 differentially affect D2 autoreceptor neurotransmission and the firing rate of midbrain dopamine neurons.
Avelar AJ; Cao J; Newman AH; Beckstead MJ
Neuropharmacology; 2017 Sep; 123():410-419. PubMed ID: 28625719
[TBL] [Abstract][Full Text] [Related]
12. The uptake inhibitors cocaine and benztropine differentially alter the conformation of the human dopamine transporter.
Reith ME; Berfield JL; Wang LC; Ferrer JV; Javitch JA
J Biol Chem; 2001 Aug; 276(31):29012-8. PubMed ID: 11395483
[TBL] [Abstract][Full Text] [Related]
13. Effects of muscarinic M1 receptor blockade on cocaine-induced elevations of brain dopamine levels and locomotor behavior in rats.
Tanda G; Ebbs AL; Kopajtic TA; Elias LM; Campbell BL; Newman AH; Katz JL
J Pharmacol Exp Ther; 2007 Apr; 321(1):334-44. PubMed ID: 17255465
[TBL] [Abstract][Full Text] [Related]
14. R-modafinil (armodafinil): a unique dopamine uptake inhibitor and potential medication for psychostimulant abuse.
Loland CJ; Mereu M; Okunola OM; Cao J; Prisinzano TE; Mazier S; Kopajtic T; Shi L; Katz JL; Tanda G; Newman AH
Biol Psychiatry; 2012 Sep; 72(5):405-13. PubMed ID: 22537794
[TBL] [Abstract][Full Text] [Related]
15. Synergistic elevations in nucleus accumbens extracellular dopamine concentrations during self-administration of cocaine/heroin combinations (Speedball) in rats.
Hemby SE; Co C; Dworkin SI; Smith JE
J Pharmacol Exp Ther; 1999 Jan; 288(1):274-80. PubMed ID: 9862781
[TBL] [Abstract][Full Text] [Related]
16. Modulation of methamphetamine's locomotor stimulation and self-administration by JHW 007, an atypical dopamine reuptake blocker.
Ferragud A; Velázquez-Sánchez C; Canales JJ
Eur J Pharmacol; 2014 May; 731():73-9. PubMed ID: 24675149
[TBL] [Abstract][Full Text] [Related]
17. Interactions between Cocaine and the Putative Allosteric Dopamine Transporter Ligand SRI-31142.
Moerke MJ; Ananthan S; Banks ML; Eltit JM; Freitas KC; Johnson AR; Saini SK; Steele TWE; Negus SS
J Pharmacol Exp Ther; 2018 Nov; 367(2):222-233. PubMed ID: 30150482
[TBL] [Abstract][Full Text] [Related]
18. Interactions of cocaine with dopamine uptake inhibitors or dopamine releasers in rats discriminating cocaine.
Li SM; Campbell BL; Katz JL
J Pharmacol Exp Ther; 2006 Jun; 317(3):1088-96. PubMed ID: 16478825
[TBL] [Abstract][Full Text] [Related]
19. Place conditioning and locomotor effects of N-substituted, 4',4''-difluorobenztropine analogs in rats.
Li SM; Newman AH; Katz JL
J Pharmacol Exp Ther; 2005 Jun; 313(3):1223-30. PubMed ID: 15743929
[TBL] [Abstract][Full Text] [Related]
20. Dual DAT and sigma receptor inhibitors attenuate cocaine effects on nucleus accumbens dopamine dynamics in rats.
Hersey M; Mereu M; Jones CS; Bartole MK; Chen AY; Cao J; Hiranita T; Chun LE; Lopez JP; Katz JL; Newman AH; Tanda G
Eur J Neurosci; 2024 May; 59(10):2436-2449. PubMed ID: 38444104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
